Clinical Trials Browser

Observational × HER2-positive Breast Cancer × pertuzumab × Clear all

NCT07470203 2026-03-13

Pyrotinib Combined With Trastuzumab and Pertuzumab for Maintenance Therapy in HER2-Positive Advanced Breast Cancer

Not yet recruiting

HER2-positive Breast Cancer